ClinHallu: A Benchmark for Diagnosing Stage-wise Hallucinations in Medical MLLM Reasoning Sicheng Yang∗1,2 , Hangjie Yuan∗‡2,3,4 , Wenjun Zhang2 , Jinwang Wang2,3 , Yichen Qian2,3 , Weihua Chen†2,3 , Fan Wang2 , Lei Zhu†1 1
The Hong Kong University of Science and Technology (Guangzhou) DAMO Academy, Alibaba Group 3 Hupan Lab 4 Zhejiang University 2
arXiv:2606.14697v1 [cs.CV] 12 Jun 2026
* Equal contribution; ‡ Project Lead; † Corresponding authors.
Building trustworthy medical multimodal large language models (MLLMs) is critical for reliable clinical decision support. Existing medical hallucination benchmarks mainly focus on data collection, but often ignore where hallucinations originate within the reasoning process. We find that hallucination sources vary across samples: errors may arise from visual misrecognition, incorrect medical knowledge recall, or flawed reasoning integration. To enable source-level hallucination diagnosis, we introduce ClinHallu, a benchmark for stage-wise hallucination diagnosis in medical MLLM reasoning. ClinHallu contains 7,031 validated instances, where each instance is augmented with a structured reasoning trace decomposed into Visual Recognition, Knowledge Recall, and Reasoning Integration. We also use stagereplacement interventions to measure how correcting specific stages affects the final answer. Beyond evaluation, we show that trace-supervised fine-tuning reduces stage-wise hallucinations. ClinHallu provides a fine-grained hallucination testbed for diagnosing and mitigating reasoning failures in medical MLLMs. The benchmark is publicly available at https://github.com/alibaba-damo-academy/ClinHallu.
Date: June 15, 2026
1
Introduction
Recent medical hallucination benchmarks have made important progress in evaluating unreliable model outputs. For example, Med-HALT (Pal et al., 2023) examines hallucination in medical LLMs, while multimodal benchmarks such as CARES (Xia et al., 2024) and Med-HallMark (Chen et al., 2024a) extend hallucination evaluation to medical vision-language models. Despite these advances, most existing evaluations remain centered on the final output: they judge whether the model’s answer or response is correct, and then use this judgment to determine whether hallucination occurs. Such evaluations can identify that a model produces an unreliable answer, but provide limited evidence about how the error arises during multimodal reasoning. As illustrated in Fig. 1, the same wrong answer may be caused by different trace-level failures: the model may misrecognize the visual evidence, recall incorrect medical knowledge, or fail to properly integrate relevant evidence and knowledge. When these distinct failure sources are collapsed into a single final-answer judgment, current benchmarks have limited ability to diagnose where
MLLMs are increasingly used in medical scenarios (Li et al., 2023a; Chen et al., 2024b; Jiang et al., 2025), including medical visual question answering (VQA) (Liu et al., 2021; Zhang et al., 2023; Zuo et al., 2025; Yao et al., 2026), report generation (Zambrano Chaves et al., 2025), and clinical decision support (Singhal et al., 2025; Tanno et al., 2025; Yang et al., 2026). These applications place high demands on reliability. However, in real-world medical use, a model may describe a non-existent lesion in an image, associate it with an incorrect clinical implication, and still present the response in a confident manner (Xia et al., 2024; Asgari et al., 2025). Such seemingly plausible but unsupported outputs are referred to as “hallucinations” (Li et al., 2023b; Liu et al., 2024; Huang et al., 2025; Ji et al., 2023). They remain a central obstacle to the reliable use of MLLMs in highstakes medical settings, as they can mislead clinical interpretation and compromise downstream medical decision-making (Pal et al., 2023; Kim et al., 2025). 1
hallucinations originate and how they propagate.
Question: What hypoattenuated tissue is between the abdominal wall and skin?
To address this limitation, we introduce ClinHallu, a benchmark for stage-wise hallucination diagnosis in medical MLLM reasoning. We construct ClinHallu from four medical VQA datasets, yielding 7,031 validated instances. ClinHallu augments each medical VQA instance with a validated reference trace decomposed into Visual Recognition, Knowledge Recall, and Reasoning Integration, and uses stage-replacement interventions to test how correcting specific stages affects the final answer. Experiments on representative MLLMs show that ClinHallu reveals stagedependent failure patterns, and quantifies how visual and knowledge errors propagate into downstream reasoning. These results demonstrate the value of ClinHallu as a fine-grained diagnostic testbed for medical MLLMs. In summary, our contributions are:
Golden Answer
MLLM
Reasoning
The CT shows a continuous hypoattenuated layer between the skin and abdominal wall. Since fat is normally subcutaneous and appears hypoattenuated on CT, the answer is fat.
Visual Hallucination
The CT shows a localized fluid-like pocket between the skin and abdominal wall. A focal subcutaneous collection can appear hypoattenuated on CT, the answer is abscess.
Knowledge Hallucination
The CT shows a continuous hypoattenuated layer between the skin and abdominal wall. Since subcutaneous hypoattenuation usually indicates abscess, the answer is abscess.
Reasoning Hallucination
The CT shows a continuous hypoattenuated layer between the skin and abdominal wall. Although this matches normal subcutaneous fat, the term “hypoattenuated” is mistaken as a pathological sign, so the answer is abscess.
Figure 1 Different reasoning failures can produce the
same wrong answer in medical VQA. In this example, the correct answer is “fat”, but visual misrecognition, incorrect knowledge recall, and flawed reasoning integration can each lead the model to answer “abscess”. This motivates ClinHallu, which diagnoses hallucinations by localizing them to specific reasoning stages rather than only judging final-answer correctness.
• We present a data curation pipeline for constructing ClinHallu, a benchmark for sourcelevel hallucination diagnosis in medical MLLMs. ClinHallu contains 7,031 validated medical VQA instances, each augmented with structured reference traces covering visual recognition, knowledge recall, and reasoning integration.
swer in incorrect visual evidence (Lyu et al., 2023), relying on inaccurate medical knowledge, or drawing an unsupported conclusion (Chang et al., 2025). Therefore, hallucination evaluation is essential for building trustworthy medical MLLMs.
• We design a stage-wise evaluation pipeline and replacement-based interventions, enabling hallucination diagnosis by identifying which reasoning stage limits final-answer correctness. We further evaluate 11 representative closed-source and open-source MLLMs on ClinHallu.
Medical hallucination benchmarks. Medical hallucina-
• We provide a fine-grained analysis of hallucination bottlenecks across datasets and models. Beyond diagnosis, we show that annotated structured traces can serve as supervision for reducing stage-wise hallucinations.
2
Knowledge
Gold (GT) Answer: fat Wrong Answer (all three): abscess
Visual
tion benchmarking has seen rapid progress. Textonly benchmarks, such as Med-HALT (Pal et al., 2023), MedHalu (Agarwal et al., 2024), and MedHallu (Pandit et al., 2025), mainly focus on hallucination detection in medical question answering, healthcare queries, and clinical knowledge assessment. Multimodal benchmarks, including CARES (Xia et al., 2024), Med-HallMark (Chen et al., 2024a), MedVH (Gu et al., 2026), MedHallBench (Zuo and Jiang, 2024), MedHallTune (Yan et al., 2025), and MedHEval (Chang et al., 2025), further extend hallucination evaluation to medical VLMs through visual question answering or trustworthiness assessment.
Related Work
Reasoning in medical MLLMs. Medical MLLMs have
recently shown strong potential in visual question answering, report understanding, and clinical decision support (Li et al., 2023a; Saab et al., 2024). Built upon general-purpose MLLMs such as GPT-4V (OpenAI, 2023), Gemini (Team et al., 2023), LLaVA (Liu et al., 2023), and Qwen-VL (Bai et al., 2023), medical variants (e.g., Med-Gemma (Sellergren et al., 2025)) adapt multimodal reasoning capabilities to specialized medical scenarios. Recent efforts also enhance medical MLLM reasoning, for example through CoT (Wei et al., 2022) and in-context learning (Brown et al., 2020; Dong et al., 2024). Nevertheless, models may produce an explanation while grounding its an-
However, existing medical hallucination benchmarks remain largely answer-centric: they can identify hallucinated outputs, but offer limited insight into their underlying sources. To address this limitation, we introduce ClinHallu, a benchmark and evaluation framework that uses structured reasoning traces to diagnose not only whether hallucination occurs, but also where it originates. A detailed comparison with existing benchmarks is provided in Table 1. 2
Table 1 Comparison with representative medical hallucination benchmarks.
We compare ClinHallu with existing benchmarks in terms of data scale, reasoning-process supervision, and hallucination evaluation. ClinHallu uniquely supports structured chain-of-thought (CoT) annotations, stage-wise traces, source localization, and hallucination rate evaluation, enabling fine-grained diagnosis of medical MLLM hallucinations.
3
Benchmark
Data Size
Multimodal
Structured CoT
Stage-wise Trace
Med-HALT MedHalu MedHallu CARES Med-HallMark MedVH MedHallTune MedHEval
18,866 2,077 10,000 41K 7,341 N/A 100K 15,976
✗ ✗ ✗ ✓ ✓ ✓ ✓ ✓
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓
✓ ✓ ✓ ✗ ✓ ✓ ✗ ✓
ClinHallu
7,031
✓
✓
✓
✓
✓
ClinHallu Benchmark
trace generator Gref produces τi = Gref (xi , qi ),
We introduce ClinHallu, a stage-wise hallucination diagnosis benchmark for MLLMs. Let xi denote the medical image or image set, qi the question, ai the ground-truth answer, and G the MLLM under evaluation. Conventional VQA evaluation compares the model prediction âi = G(xi , qi ) with ai , which only measures final-answer correctness and leaves the reasoning process unexamined.
(1)
(3)
Trace validation and filtering. Since reference traces
where τi records the reference reasoning process leading to the answer. Accordingly, each model is asked to generate both a trace and an answer, (τ̂i , âi ) = G(xi , qi ),
τi = (vi , ki , ri ).
Here, vi , ki , and ri denote Visual Recognition, Knowledge Recall, and Reasoning Integration, respectively. For example, in Fig. 2, the trace first observes that the brain image contains bright fluid, then recalls that fluid is bright in “T2-weighted MRI” but dark in “T1-weighted MRI”, and finally connects the observation with this rule to answer “T2-weighted MRI”. This decomposition separates visual evidence, medical knowledge, and their integration, enabling stagewise hallucination analysis.
As illustrated in Fig. 2, ClinHallu augments each VQA sample di with a validated structured trace: di ClinHallu = (xi , qi , τi , ai ),
Hallucination Hallucination Source Loc. Rate Eval.
are generated at scale, we further filter them to ensure their reliability. For each generated trace τi = (vi , ki , ri ), we apply an LLM-as-judge model J(·) to evaluate two criteria: format validity and answer consistency:
(2)
so that hallucinations can be localized by comparing the generated τ̂i with the reference τi , with detailed definitions provided below.
ans (cfmt i , ci ) = J(τi , xi , ai ),
(4)
tive medical VQA datasets: VQA-RAD (Lau et al., 2018), PathVQA (He et al., 2020), MedFrameQA (Yu et al., 2025), and MedXpertQA (Zuo et al., 2025). They provide complementary coverage across medical domains, imaging modalities, and task formulations.
where cfmt checks whether the trace follows the rei quired three-stage format and whether all stages are non-empty, and cans checks whether the trace supi ports the ground-truth answer ai without introducing conflicting conclusions. We retain a trace only when both criteria are satisfied: (5) ϕ(τi ) = 1 cfmt ∧ cans . i i
Structured reasoning trace construction. We augment
The final benchmark is then defined as
Source data. ClinHallu integrates four representa-
each standardized VQA sample with a structured reference reasoning trace. Given xi and qi , a reference
DClinHallu = {(xi , qi , τi , ai ) | ϕ(τi ) = 1}. 3
(6)
Source datasets
Trace generation
VQA-RAD
Trace Filtering
PathVQA (52.81%) MedFrameQA (24.3%)
Path-VQA
MedXpertQA (18.1%)
Format Filtering
Trace MedFrameQA
MedXpertQA
VQA-RAD (4.79%)
R
K
V
Visual Recognition
ClinHallu
Q: What imaging modality is this?
Knowledge Recall
V: Brain image; fluid appears bright K: T1: fluid dark; T2: fluid bright R: Fluid matches T2 characteristics
Answer Acc
Answer
Reasoning Integration
V
K
R
A: T2-weighted MRI
Figure 2 Overview of the ClinHallu construction pipeline. ClinHallu integrates four medical VQA datasets and augments
each sample with a structured reasoning trace covering Visual Recognition (V), Knowledge Recall (K), and Reasoning Integration (R). Generated traces are filtered by format validity and answer consistency, yielding validated stage-wise annotations for diagnosing hallucination sources in medical MLLM reasoning.
4.2
This filtering step ensures that retained traces are complete and answer-consistent, providing reliable references for downstream evaluation.
We first evaluate whether the final answer produced by the candidate MLLM is correct. For each instance, an answer judge J(·) compares the predicted answer âi with the ground-truth answer ai and assigns a binary correctness label:
After filtering, DClinHallu contains 7,031 validated VQA instances from four source datasets. Each instance includes the original multimodal sample and a three-stage reference trace, supporting stage-wise hallucination analysis. As shown in Table 1, prior benchmarks typically focus on text-only hallucination or lack structured reasoning traces for multimodal settings. ClinHallu instead combines multimodal inputs, structured CoT annotations, source localization, and hallucinationrate evaluation, enabling fine-grained diagnosis of medical MLLM failures. Released benchmark instances.
4
Evaluation
4.1
Evaluation Overview
Answer-Level Evaluation
ci = J(xi , âi , ai ),
ci ∈ {0, 1},
(7)
where ci = 1 indicates a correct answer and ci = 0 otherwise. The answer-level accuracy is: |D|
Acc =
1 X ci . |D| i=1
(8)
However, final-answer accuracy cannot identify the source of an error. We therefore introduce stagewise hallucination evaluation to localize failures in different sources, i.e. visual recognition, knowledge recall, and reasoning integration.
4.3
ClinHallu evaluates both final-answer correctness and the source of hallucinations in the reasoning process. As illustrated in Fig. 3, for each instance xi , the evaluated model first generates a structured trace τ̂i = (v̂i , k̂i , r̂i ) and then produces answer âi . Given the reference trace τi = (vi , ki , ri ) and answer ai , ClinHallu conducts three evaluations: (1) answerlevel evaluation, which measures whether âi matches ai ; (2) stage replacement intervention, which replaces selected generated stages with reference stages (e.g., v̂i → vi ) to obtain decoupled stage-wise evaluations; and (3) stage-wise diagnosis, which reports hallucination rates at each stage and measures replacementinduced answer-accuracy changes.
Stage-Wise Evaluation
Reasoning hallucinations may arise from upstream errors in visual recognition or knowledge recall, leading to a cascading effect. To disentangle these and identify which stage contributes most to hallucination, we apply stage replacement interventions to decouple the structured CoT, and then analyze hallucination rates and answer accuracy before and after replacement. As illustrated in Fig. 3 (b), for each intervention, one or more generated stages are replaced with their reference counterparts, and the evaluated MLLM G is asked to continue the remaining reasoning process and produce a new answer. Specifically, for each instance xi , Stage replacement intervention.
4
(a) Model Prediction Q: imaging modality?
MLLM
(b) Stage-wise Replacement Rep-V
V
Rep-K
V
Rep-VK
V
Vision Knowledge Reasoning
K ...R ...A ... A R K ... ... R K A ... ...
MLLM
Rep-V
V Brain image; V: fluid appears dark
V Brain image; V: fluid appears bright
K: K T1: fluid dark; T2: fluid bright
K T1: fluid dark;
V
K
R
A
MLLM
V
K
R
A
A
T1 MRI
80.4
65.9 Qwen2.5
82.5
25.7
R Fluid matches T2 characteristics
T1 characteristics
A
GT
T2: fluid bright
R: Fluid matches R
Answer
(c) Stage-wise Judging
Gemini3
T2 MRI
H𝑉
H𝐾
H𝑅
Acc
Figure 3 Evaluation protocol of ClinHallu. Given a medical VQA sample, the evaluated MLLM generates a structured
trace and final answer. We then replace selected generated stages with validated reference stages and ask the model to complete the remaining reasoning process. The resulting traces and answers are judged against the references to compute stage-wise hallucination rates (HV , HK , HR ) and answer accuracy (Acc), enabling diagnosis of the main bottleneck in medical MLLM reasoning.
let (vi , ki , ri , ai ) denote the reference output, and let (v̂i , k̂i , r̂i , âi ) denote the output generated by G.
the reasoning stage generated after replacing both visual and knowledge stages, as defined in Eq. 11. A value of 1 indicates that the corresponding stage contains hallucinated content. We then compute the hallucination rate for each stage:
For visual-stage replacement, the reference visual stage vi is provided, and G generates the remaining knowledge, reasoning, and answer: Rep-V :
(k̂i , r̂i , âi ) = G(xi , vi ).
(9)
|D|
1 X s h , H = |D| i=1 i s
For knowledge-stage replacement, the generated visual stage v̂i is retained while the reference knowledge stage ki is provided: Rep-K :
(r̂i , âi ) = G(xi , v̂i , ki ).
(r̂i , âi ) = G(xi , vi , ki ).
(10)
In addition to hallucination rates, we use answer accuracy changes to diagnose which upstream stage most affects final-answer correctness. For each replacement setting s ∈ {Rep-V, Rep-K, Rep-VK}, we compute the average accuracy gain over all evaluated models:
Accuracy diagnosis.
(11)
Hallucination rate evaluation. We assess each stage
under the intervention context where its upstream stages are fixed to reference counterparts. Specifically, the hallucination labels for each stage are defined as:
∆sAcc =
1 X Accsm − AccORG , m |M|
(14)
m∈M
hVi = J(xi , v̂i , vi ), hK i = J(xi , k̂i,REP-V , ki ),
(13)
By controlling upstream stages through replacement, these hallucination rates directly reflect the model’s hallucination tendency at each stage.
For joint visual-and-knowledge replacement, both reference stages vi and ki are provided, and G generates only the remaining r̂i and âi : Rep-VK :
s ∈ {V, K, R}.
where AccORG denotes the original answer accuracy m of model m defined by the answer judge in Eq. 8, and Accsm denotes its answer accuracy under replacement setting s. A larger ∆sAcc indicates that correcting the corresponding stage leads to a greater improvement in final-answer correctness, suggesting that this stage is a more important bottleneck in the reasoning process.
(12)
hR i = J(xi , r̂i,REP-VK , ri ), R where hVi , hK i , hi ∈ {0, 1}. Here, k̂i,REP-V denotes the knowledge stage generated after replacing the visual stage, as defined in Eq. 9, and r̂i,REP-VK denotes
5
Table 2 Accuracy and stage-wise hallucination rates on ClinHallu. We report accuracy (Acc; Eq. 8) and hallucination rates (Eq. 13) for Visual Recognition (HV ), Knowledge Recall (HK ), and Reasoning Integration (HR ). Within each model group, the best value for each metric is highlighted in bold. VQA-RAD
Model
Acc↑ HV ↓ HK ↓
PathVQA HR ↓
Acc↑ HV ↓ HK ↓
MedFrameQA HR ↓
Acc↑ HV ↓ HK ↓
MedXpertQA
AVG
HR ↓
Acc↑ HV ↓ HK ↓
HR ↓
Acc↑ HV ↓ HK ↓
HR ↓
Closed-source MLLMs Qwen3-VL-Flash 70.9 Qwen3-VL-Plus 74.2 Gemini-3-Flash 82.5
50.7 44.5
9.2 6.8
6.8 3.9
72.4 72.9
45.7 41.9
13.5 6.7
7.0 5.2
64.0 65.9
51.0 46.7
17.8 10.9
9.1 7.6
47.1 55.9
61.1 55.8
39.4 25.6
7.4 2.1
63.6 67.2
52.1 47.2
20.0 12.5
7.6 4.7
22.9
3.6
3.0
81.6
21.5
2.8
1.9
71.3
31.0
5.5
3.0
85.0
27.6
4.2
1.3
80.1
25.8
4.0
2.3
54.9 65.0 65.3 71.8 69.7 78.6 77.7
59.4 57.0 45.1 38.0 35.0 47.8 38.9
34.1 17.2 12.2 24.3 13.7 9.5 14.0
12.5 4.2 8.9 14.2
46.0 55.0 64.8 60.2 58.7 63.6 69.7
61.2 55.4 48.8 50.1 44.3 47.7 50.3
38.0 23.4 19.8 29.5 21.6
8.4 5.2 5.1 13.6 3.2
40.8
43.9 32.6 25.6 30.1 21.1
2.7
65.9 60.5 52.2 51.1 45.6 50.8 52.0
45.5 33.2 27.3 33.4 26.6 18.8 30.5
32.3
6.2
72.7
34.7
2.2
70.7
29.7 18.6
42.7 51.5 52.7 53.2 53.9 63.8 64.3
80.4
49.7 53.0 41.5
65.8 59.7 51.5 49.8 49.9 37.8 54.2
18.1 7.8 13.6 30.5 6.6
24.2 14.2
24.7 32.0 27.7 26.4 26.5 47.2 43.8
22.3 7.0 16.9 61.7 10.2
2.2
29.1 14.7 23.5 32.4 10.2 9.4 8.6
78.2 71.4 65.6 64.1 62.5
11.4
45.3 53.9 53.0 54.6 60.5 65.7 66.0
8.1
52.6
69.1
41.9
18.7
Open-source MLLMs Qwen2.5-VL-7B Qwen3-VL-8B Lingshu-7B MedGemma-4B InternVL3.5-8B Qwen3-VL-32B Qwen3.5-4B Qwen3.5-9B
4.4
2.7
3.0 3.3 3.3
Evaluation after Training with Traces
Experiments
5.1
Experimental Setup
16.3
58.1
66.0 58.9
35.8
3.1
5.9 5.6
4.4
5.1 4.8
Implementation details. All local open-source models
are served using the vLLM framework (Kwon et al., 2023). For CoT generation, we set the temperature to 0.7 to encourage diverse reasoning traces. For finalanswer judging and stage-wise hallucination judging, we use a lower temperature of 0.01 to ensure deterministic and reproducible evaluation. The prompts used for each stage are provided in Appendix C.
To examine whether the structured traces in ClinHallu can also serve as effective supervision, we conduct trace-supervised fine-tuning on Qwen3.5-9B. Since MedFrameQA and MedXpertQA do not include training sets, we restrict fine-tuning to VQARAD and PathVQA. We construct golden traces for their training splits using the same trace generation pipeline and evaluate the fine-tuned models on the corresponding test sets in ClinHallu. Detailed finetuning configurations are provided in Appendix A.
5
64.8 58.2 49.4 52.3
5.2
Results Analysis
Finding 1.Visual hallucination is generally severe; VQA-RAD is visual-bottlenecked, MedXpertQA is knowledge-bottlenecked, while PathVQA and MedFrameQA are relatively balanced. Table 2 first reveals distinct dataset-level hallucination patterns. Across all subsets, visual hallucination is consistently high, with average rates exceeding 40%. On VQA-RAD, visual hallucination is the dominant error source, with an average rate of 42.9% across models, far higher than knowledge hallucination at 13.7%. MedXpertQA exhibits a different pattern: knowledge hallucination becomes much more severe, reaching 43.1%. By contrast, PathVQA and MedFrameQA show more balanced visual–knowledge error profiles. Tables 3 and 4 lead to the same conclusion based on answer-accuracy changes. Correcting the visual stage on VQA-RAD improves Acc by 15.5%, much larger than the 4.6% gain from correcting knowledge. In contrast, MedXpertQA benefits more from knowledge replacement, with a 33.4% gain compared with 13.8% from Rep-V. PathVQA and MedFrameQA again show more comparable gains between V/K replacement. These results indicate hallucination bottlenecks are dataset-dependent.
Evaluation models. We evaluate a set of both closed-
and open-source MLLMs. The closed-source models comprise Qwen3-VL-Flash (Bai et al., 2025a), Qwen3-VL-Plus (Bai et al., 2025a), and Gemini-3Flash. The open-source models include Qwen2.5-VL7B (Bai et al., 2025b), Qwen3-VL-8B (Bai et al., 2025a), Lingshu-7B (Xu et al., 2025), MedGemma4B (Sellergren et al., 2025), InternVL3.5-8B (Wang et al., 2025), Qwen3-VL-32B (Bai et al., 2025a), and two more recent Qwen variants: Qwen3.5-4B (Qwen Team, 2026), and Qwen3.5-9B (Qwen Team, 2026). For benchmark construction and evaluation, Qwen3.5Plus (Qwen Team, 2026) serves as the generator Gref for golden CoT trace construction, as defined in Eq. 3. We use Qwen3.5-27B (Qwen Team, 2026) as the judge model J for both trace validation and evaluation, including answer correctness and hallucination analysis, as defined in Eqs. 4, 7, and 12. 6
Table 3 Accuracy diagnosis under stage-replacement interventions on ClinHallu. For each subset, we report the original VK answer accuracy (Acc), computed using Eq. 8, and the corresponding accuracy gains, ∆VAcc , ∆K Acc , and ∆Acc , following Eq. 14. Darker blue cells indicate larger gains. Higher ↑ is better.
VQA-RAD
Model
PathVQA
Acc↑
VK ∆VAcc ↑ ∆K Acc ↑ ∆Acc ↑ Acc↑
VK ∆VAcc ↑ ∆K Acc ↑ ∆Acc ↑ Acc↑
70.9 74.2
+19.9 +17.5 +12.5
+11.0 +10.9 +4.8
MedFrameQA
MedXpertQA
VK ∆VAcc ↑ ∆K Acc ↑ ∆Acc ↑ Acc↑
VK ∆VAcc ↑ ∆K Acc ↑ ∆Acc ↑
+15.6 +16.3 +27.6 +16.0 +13.5 +25.8 +14.3 +15.7 +22.1
+16.3 +32.3 +44.2 +18.5 +25.4 +40.8 +8.3 +7.5 +13.5
Closed-source MLLMs Qwen3-VL-Flash Qwen3-VL-Plus Gemini-3-Flash
82.5
+4.8 +2.7 +1.5
+22.3 +19.0 +12.2
72.4 72.9 81.6
+9.9 +7.9 +5.4
+18.7 +18.2 +8.7
64.0 65.9 71.3
47.1 55.9 85.0
Open-source MLLMs Qwen2.5-VL-7B Qwen3-VL-8B Lingshu-7B MedGemma-4B InternVL3.5-8B Qwen3-VL-32B Qwen3.5-4B Qwen3.5-9B
54.9 65.0 65.3 71.8 69.7 78.6 77.7 80.4
+22.2 +21.9 +18.1 +6.8 +16.9 +11.0 +11.9 +11.6
+6.8 +3.9 +5.9 +9.5 +5.1 +2.1 +4.2 +3.9
+32.6 +28.2 +23.4 +11.3 +25.5 +15.7 +15.1 +14.2
46.0 55.0 64.8 60.2 58.7 63.6 69.7 72.7
+19.8 +19.7 +10.5 +8.8 +17.3 +19.1 +8.7 +9.2
+16.7 +13.3 +15.3 +16.0 +17.9 +12.3 +10.0 +10.3
Table 4 Average gains under stage-replacement interventions.